China’s Baby Boom Fuels Dairy & Biotech Growth
China’s birth rate subsidies, once dismissed as a stopgap measure, are now catalyzing a seismic shift in global markets. With infant formula consumption surging and policy tailwinds driving demand for premium ingredients like human milk oligosaccharides (HMOs), strategic investors are eyeing two sectors: European biotech firms with HMO production patents and undervalued Chinese dairy stocks […]